Cancer Screening for All Through the Power of Tears

Our name, Namida, is derived from the Japanese word for tears, reflecting our focus on utilizing the power of tears to identify early-stage cancers. We use cutting-edge proteomics and genomics …

A clinical tear-based biological breast cancer screening for providers. Melody requires no specialized equipment or personnel, making it ideally suited for any walk-in diagnostic clinic. Meet Melody

Oct 31, 2023 · Let’s disrupt. We’re a revenue stage biotech company with big ideas, and the science to make them happen. Be a part of the future of cancer screening. Subscribe to our email newsletter …

Jan 21, 2022 · Namida Lab Inc. is an Arkansas-based biotech company specializing in biomarker-based testing to improve diagnostic testing and patient outcomes. Namida’s first product, Melody® is an …

Sep 30, 2021 · Namida was founded in 2019 and has assembled a talented team with experience across diagnostic, medical information, and scientific automation fields to develop a diagnostic …

Namida is monitored periodically by CMS through proficiency testing (PT). Since our test utilizes a “non-regulated” analyte, we designed our proficiency testing protocol using Federal (CLIA) Regulations …

Sep 29, 2021 · Namida Lab and CARTI Partner to Study Proteins in Cancer Patients’ Tears Press Release December 17, 2021

Mar 9, 2022 · Applying their Pattern Discovery Engine™ to Namida Lab’s data, Pattern Computer significantly increased Namida Lab’s predictive accuracy for breast cancer screening, and …

Namida was founded in 2019 and has assembled a talented team with experience across biochemistry, diagnostics, bioinformatics, medical information, and scientific automation fields to develop a …